Please use this identifier to cite or link to this item: https://doi.org/10.3802/jgo.2021.32.e31
DC FieldValue
dc.titleA single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
dc.contributor.authorLee, Yong Jae
dc.contributor.authorLim, Myong Cheol
dc.contributor.authorKim, Byoung-Gie
dc.contributor.authorNgoi, Natalie YL
dc.contributor.authorChoi, Chel Hun
dc.contributor.authorPark, Sang-Yoon
dc.contributor.authorTan, David SP
dc.contributor.authorGo, Yunjung
dc.contributor.authorLee, Jung-Yun
dc.date.accessioned2021-02-08T01:24:08Z
dc.date.available2021-02-08T01:24:08Z
dc.date.issued2020
dc.identifier.citationLee, Yong Jae, Lim, Myong Cheol, Kim, Byoung-Gie, Ngoi, Natalie YL, Choi, Chel Hun, Park, Sang-Yoon, Tan, David SP, Go, Yunjung, Lee, Jung-Yun (2020). A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01). Journal of Gynecologic Oncology 32. ScholarBank@NUS Repository. https://doi.org/10.3802/jgo.2021.32.e31
dc.identifier.issn20050380
dc.identifier.issn20050399
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/186260
dc.publisherAsian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy
dc.sourceElements
dc.typeArticle
dc.date.updated2021-02-08T01:10:09Z
dc.contributor.departmentMEDICINE
dc.description.doi10.3802/jgo.2021.32.e31
dc.description.sourcetitleJournal of Gynecologic Oncology
dc.description.volume32
dc.published.stateUnpublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
OPEB1 protocol paper_jgo-32-e31.pdf1.39 MBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.